Search

everythinglearnresearchcommunity

for

Search:↓

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Hair loss can cause significant social and emotional issues, especially for women and young men.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Tofacitinib may help treat severe hair loss, but more research is needed.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.